In our analyses of known TCGA gastric cancer drivers, for instance, we showed that only approximately 60% had clonal mutations, raising questions about the initiation versus progression “driver” status of genes such as CIC, NF1, KIF13A, PTPN23, and CHRD, which were mutated in multiple patients but always nonclonally. The gene discussed is CHRD; the disease is gastric cancer.